Estetrol for treatment of advanced ER+/HER2-breast cancer

被引：3
|
作者：
Schmidt, Marcus [1 ]
Hoenig, Arnd [2 ]
Zimmerman, Yvette [3 ]
Verhoeven, Carole [3 ]
Almstedt, Katrin [1 ]
Battista, Marco [1 ]
Lenhard, Hans Georg [2 ]
Krijgh, Jan [3 ]
Bennink, Herjan Coelingh [3 ]
机构：
[1] Univ Med Ctr, Mainz, Germany
[2] Catholic Hosp, Mainz, Germany
[3] Pantarhei Oncol, Zeist, Netherlands
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P5-11-15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-11-15
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Discovery of CDK4/6 bifunctional degraders for ER+/HER2-breast cancer andtriple negative breast cancer
    Majeski, Hannah
    Okano, Akinori
    Pasis, Angela
    Carlson, Casey
    Liu, Qiao
    Shakya, Arvind
    Huang, Shenlin
    Chourasia, Aparajita Hoskote
    Fung, Leah
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [32] Prediction of CDK inhibitor efficacy in ER+/HER2-breast cancer using machine learning algorithms
    Mason, Jeremy
    Gong, Yutao
    Amiri-Kordestani, Laleh
    Wedam, Suparna
    Gao, Jennifer J.
    Singh, Harpreet
    Pazdur, Richard
    Kuhn, Peter
    Blumenthal, Gideon
    Beaver, Julia A.
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [33] Randomized phase II trial of preoperative fulvestrant with or without enzalutamide for ER+/Her2-breast cancer
    Elias, Anthony D.
    Staley, Alyse
    Fornier, Monica
    Vidal, Gregory A.
    Sams, Sharon
    Spoelstra, Nicole
    Kabos, Peter
    Diamond, Jennifer R.
    Shagisultanova, Elena
    Gallagher, Rosa I.
    Wulfkuhle, Julia
    Petricoin, Emanuel
    Zolman, Kathryn
    Biller, Stephanie
    Alami, Vida
    McSpadden, Tessa
    Borges, Virginia
    Crump, Lyndsey S.
    Gao, Dexiang
    Richer, Jennifer K.
    [J]. CANCER RESEARCH, 2023, 83 (08)
  • [34] Laboratory analyses of metastatic ER+/Her2-breast cancer treated with fulvestrant plus enzalutamide.
    Richer, Jennifer K.
    Spoelstra, Nicole S.
    Winchester, Alyse
    Wulfkuhle, Julia
    Sams, Sharon B.
    Vidal, Gregory
    Kabos, Peter
    Diamond, Jennifer
    Shagisultanova, Elena
    Afghahi, Anosheh
    Mayordomo, Jose
    McSpadden, Tessa
    Crawford, Gloria
    Borges, Virginia
    Gao, Dexiang
    Petricoin, Emanuel
    Elias, Anthony D.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [35] Assessing the performance and possibility of overfitting of different algorithm development methods used to define advanced stage ER+/HER2-breast cancer
    D'Arcy, Monica
    Sturmer, Til
    Lund, Jennifer L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 124 - 124
  • [36] Early metabolic response assessment to neoadjuvant endocrine treatment in ER+, HER2-breast cancer: comparison to the morphological and pathological response
    Boughdad, Sarah
    Champion, Laurence
    Becette, Veronique
    Cherel, Pascal
    Mouret-Fourme, Emmanuelle
    Edeline, Veronique
    Lemonnier, Jerome
    Lerebours, Florence
    Alberini, Jean-Louis
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [37] Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project
    Peixoto, Ana
    Cirnes, Luis
    Carvalho, Ana Luisa
    Andrade, Maria Joao
    Brito, Maria Jose
    Borralho, Paula
    Coimbra, Nuno
    Borralho, Pedro M.
    Carneiro, Ana Sofia
    Castro, Lisandra
    Correia, Lurdes
    Dionisio, Maria Rita
    Faria, Carlos
    Figueiredo, Paulo
    Gomes, Ana
    Paixao, Joana
    Pinheiro, Manuela
    Prazeres, Hugo
    Ribeiro, Joana
    Salgueiro, Natalia
    Schmitt, Fernando C.
    Silva, Fatima
    Silvestre, Ana Rita
    Sousa, Ana Carla
    Almeida-Tavares, Joana
    Teixeira, Manuel R.
    Andre, Saudade
    Machado, Jose Carlos
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [38] Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project
    Peixoto, Ana
    Cirnes, Luis
    Carvalho, Ana Luisa
    Andrade, Maria Joao
    Brito, Maria Jose
    Borralho, Paula
    Borralho, Pedro M.
    Carneiro, Ana Sofia
    Castro, Lisandra
    Correia, Lurdes
    Dionisio, Maria Rita
    Faria, Carlos
    Figueiredo, Paulo
    Gomes, Ana
    Paixao, Joana
    Pinheiro, Manuela
    Prazeres, Hugo
    Ribeiro, Joana
    Salgueiro, Natalia
    Schmitt, Fernando C.
    Silva, Fatima
    Silvestre, Ana Rita
    Sousa, Ana Carla
    Almeida-Tavares, Joana
    Teixeira, Manuel R.
    Andre, Saudade
    Machado, Jose Carlos
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [39] Predicting sensitivity to CDK4/6 inhibition in ER+/HER2-breast cancer cell lines
    Bathurst, Lauren
    Liao, Linda
    Crozier, Cheryl
    Bayani, Jane
    Bartlett, John
    Spears, Melanie
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [40] Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2-breast cancer
    Moldoveanu, Dan
    Hoskin, Tanya L.
    Day, Courtney N.
    Schulze, Amy K.
    Goetz, Matthew P.
    Boughey, Judy C.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (03) : 419 - 428
12345